145 related articles for article (PubMed ID: 37092074)
1. Willingness-to-pay for a population-based-prostate-specific antigen screening for prostate cancer in Anambra State, Southeast, Nigeria: a contingent valuation study.
Umeh BI; Ogbonna BO; Nduka SO; Nduka JI; Ejie LI; Mosanya UA; Ekwunife IO
Afr Health Sci; 2022 Dec; 22(4):46-55. PubMed ID: 37092074
[TBL] [Abstract][Full Text] [Related]
2. Mothers' willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study.
Umeh IB; Nduka SO; Ekwunife OI
Cost Eff Resour Alloc; 2016; 14():8. PubMed ID: 27274335
[TBL] [Abstract][Full Text] [Related]
3. Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey.
Yasunaga H; Sugihara T; Imamura T
Urology; 2011 Jun; 77(6):1325-9. PubMed ID: 21507471
[TBL] [Abstract][Full Text] [Related]
4. Willingness to pay for community-based health insurance in Nigeria: do economic status and place of residence matter?
Onwujekwe O; Okereke E; Onoka C; Uzochukwu B; Kirigia J; Petu A
Health Policy Plan; 2010 Mar; 25(2):155-61. PubMed ID: 20156920
[TBL] [Abstract][Full Text] [Related]
5. Willingness to pay for the maintenance of equity in a local ivermectin distribution scheme in Toro, Northern Nigeria.
Onwujekwe OE; Shu EN; Okonkwo PO
Public Health; 1999 Jul; 113(4):193-4. PubMed ID: 10483083
[TBL] [Abstract][Full Text] [Related]
6. Willingness to Pay for a Contributory Social Health Insurance Scheme: A Survey of Rural Residents in Akwa Ibom State, Nigeria.
Akwaowo CD; Umoh I; Motilewa O; Akpan B; Umoh E; Frank E; Nna E; Okeke U; Onwujekwe OE
Front Public Health; 2021; 9():654362. PubMed ID: 34222168
[No Abstract] [Full Text] [Related]
7. How do patients prefer specialized clinical pharmacy service to other prevention of mother-to-child transmission of human immunodeficiency virus services? An evaluation of their willingness to pay and willingness to accept choices and ratios.
Isah A; Adibe MO; Abba A; Dim OF; Ekwuofu AA; Ma'aji HU; Ukwe CV; Udeogaranya PO; Okonta MJ
J Clin Pharm Ther; 2021 Dec; 46(6):1695-1705. PubMed ID: 34448210
[TBL] [Abstract][Full Text] [Related]
8. Men's willingness to pay for prostate cancer screening: a systematic review.
Farabi H; Rezapour A; Moradi N; Aghamir SMK; Koohpayehzadeh J
Syst Rev; 2020 Dec; 9(1):290. PubMed ID: 33298175
[TBL] [Abstract][Full Text] [Related]
9. Willingness-to-Accept and Willingness-to-Pay Ratios of Prevention of Mother-to-Child Transmission Services in a Nigerian Hospital: A Cross-Sectional Contingent Valuation Study.
Isah A; Adibe MO; Anosike C; Aluh DO; Onyekwelu PO; Okonta MJ; Ukwe CV
Value Health Reg Issues; 2019 Sep; 19():112-121. PubMed ID: 31404819
[TBL] [Abstract][Full Text] [Related]
10. Benefit evaluation of mass screening for prostate cancer: willingness-to-pay measurement using contingent valuation.
Yasunaga H; Ide H; Imamura T; Ohe K
Urology; 2006 Nov; 68(5):1046-50. PubMed ID: 17113896
[TBL] [Abstract][Full Text] [Related]
11. Willingness to enroll and pay for community-based health insurance, decision motives, and associated factors among rural households in Enugu State, Southeast Nigeria.
Oluedo EM; Obikeze E; Nwankwo C; Okonronkwo I
Niger J Clin Pract; 2023 Jul; 26(7):908-920. PubMed ID: 37635574
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria.
Agada-Amade YA; Ogbuabor DC; Obikeze E; Eborieme E; Onwujekwe OE
BMC Nephrol; 2024 Jan; 25(1):29. PubMed ID: 38262948
[TBL] [Abstract][Full Text] [Related]
13. Willingness to pay for packaging cancer screening of Chinese rural residents.
Zhang Q; Ren D; Chang X; Sun C; Liu R; Wang J; Zhang N
Cancer Med; 2023 Feb; 12(3):3532-3542. PubMed ID: 36000818
[TBL] [Abstract][Full Text] [Related]
14. Willingness to pay for mass screening for prostate cancer: a contingent valuation survey.
Yasunaga H
Int J Urol; 2008 Jan; 15(1):102-5; discussion 105. PubMed ID: 18184186
[TBL] [Abstract][Full Text] [Related]
15. Cost benefit analysis of malaria rapid diagnostic test: the perspective of Nigerian community pharmacists.
Ezennia IJ; Nduka SO; Ekwunife OI
Malar J; 2017 Jan; 16(1):7. PubMed ID: 28049466
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing willingness and ability to pay for social health insurance in Nigeria.
Ogundeji YK; Akomolafe B; Ohiri K; Butawa NN
PLoS One; 2019; 14(8):e0220558. PubMed ID: 31374083
[TBL] [Abstract][Full Text] [Related]
17. Willingness to pay for antiretroviral therapy, viral load, and premium services; A contingent valuation survey of people living with HIV in southern Nigeria.
Sanwo O; Iyamu I; Idemudia A; Badru T; Ekponimo S; Oqua D; Makinde OA; Aliyu GG; Kola-Jebutu A; Egwuagu-Pius J; Obiora-Okafo C; Bateganya M; Apera I; Pandey SR; Khamofu H
PLoS One; 2023; 18(11):e0289507. PubMed ID: 37972145
[TBL] [Abstract][Full Text] [Related]
18. Knowledge of prostate cancer screening among native African urban population in Nigeria.
Ajape AA; Babata A; Abiola OO
Nig Q J Hosp Med; 2009; 19(3):145-7. PubMed ID: 20836318
[TBL] [Abstract][Full Text] [Related]
19. Knowledge of prostate cancer screening among native African urban population in Nigeria.
Ajape AA; Babata A; Abiola OO
Nig Q J Hosp Med; 2010; 20(2):94-6. PubMed ID: 21243859
[TBL] [Abstract][Full Text] [Related]
20. Patients' willingness to pay for the treatment of tuberculosis in Nigeria: exploring own use and altruism.
Ochonma OG; Onwujekwe OE
Int J Equity Health; 2017 May; 16(1):74. PubMed ID: 28486981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
